2026-04-13T13:45:26Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1752942025-11-19T10:41:16Zcom_2072_1057col_2072_478815col_2072_478916col_2072_478917

urn:hdl:2445/175294 OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion Esteve Pitarch, Erika Padullés Zamora, Ariadna Maisterra-Santos, Kristel Colom Codina, Helena Cobo Sacristán, Sara Antibiòtics betalactàmics Medicina intensiva Farmacocinètica Beta lactam antibiotics Critical care medicine Pharmacokinetics Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem. 2021-03-18T09:33:27Z 2021-03-18T09:33:27Z 2019 2021-03-18T09:33:27Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Reproducció del document publicat a: https://doi.org/10.7399/fh.11170 Farmacia Hospitalaria, 2019 https://doi.org/10.7399/fh.11170 cc by-nc-sa (c) Sociedad Española de Farmacia Hospitalaria, 2019 http://creativecommons.org/licenses/by-nc-sa/3.0/es/ info:eu-repo/semantics/openAccess Sociedad Española de Farmacia Hospitalaria Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)